An amyloidosis diagnosis can take upwards of 2 years.Initial symptoms often are nondescript, and irreversible organ damage frequently occurs before disease confirmation.

MONTREAL — Levels of neurofilament light chain (Nfl) may be a biomarker of chemotherapy-induced peripheral neurotoxicity (PIPN), new research suggests. Investigators found Nfl levels increased in ...

The single-stranded DNA molecules developed by researchers using the SELEX technology could transform blood testing for Alzheimer's biomarkers. These synthetic aptamers target neurofilament light ...

AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death. Clonal plasma cells in the bone marrow secrete free ...

Mortality trends (1999-2022) in patients with multiple myeloma with pneumonia, influenza, and COVID-19. Outcomes of myeloma cast nephropathy in the era of anti-CD38 monoclonal antibody-based frontline ...

Please provide your email address to receive an email when new articles are posted on . EMPHASIS study included 258 persons with MS given vidofludimus calcium or placebo for 24 weeks. Results show ...

In the companion to this commentary in JCO Oncology Practice, Dima et al 1 provided a scholarly review on the diagnosis, increased awareness, and treatment of immunoglobulin light chain (AL) ...

On June 12th, 2023 local time, Sanyou Biopharmaceuticals Co., Ltd. officially announced the launch of "Sanyou Super Trillion Common Light Chain Antibody Discovery Platform" (the "platform"). As one of ...